Sydney Jennings

Articles

Topical Acne Therapies: A Clinical Update

February 16, 2025

Insights include new data on combination therapies, topical antiandrogens, and innovative retinoid formulations.

Key Advances in Oral Therapies for Psoriasis Unveiled at Winter Clinical Dermatology Conference 2025

February 15, 2025

April Armstrong, MD, discussed the latest data on apremilast, deucravacitinib, and emerging TYK2 and IL-23 inhibitors at Midwinter Hawaii.

Oral Antiviral Candidate Shows Promise for RSV Treatment: Daily Dose

February 14, 2025

Your daily dose of the clinical news you may have missed.

Ozempic Approval Expanded to Include Patients with T2D and CKD: Daily Dose

February 13, 2025

Your daily dose of the clinical news you may have missed.

Postnatal Antibiotics for Maternal Indications May Heighten Childhood Asthma Risk

February 12, 2025

AAAAI 2025. Early postnatal antibiotic exposure in full-term infants was associated with a 30% increased risk of childhood asthma, according to a new study.

AAAAI 2025: Omalizumab Shows Favorable Outcomes Versus Oral Immunotherapy in Multi‐Food Allergy Treatment

February 12, 2025

In a randomized clinical trial, omalizumab achieved a 36% treatment success rate for multi-food allergy compared with 19% for oral immunotherapy.

Investigational Nonopioid Beats Placebo in Phase 3 Trial: Daily Dose

February 12, 2025

Your daily dose of the clinical news you may have missed.

Investigational Cell Therapy Cuts Insulin Dependency in Late-Stage Type 2 Diabetes

February 11, 2025

CELZ-201 reduced insulin dependency and stabilized HbA1c in 1-year follow-up data from a pilot study in T2D.

New Biomarkers Identified for Early Detection of Alzheimer Disease

February 11, 2025

Phospho-tau serine-262 and serine-356 were identified as biomarkers for early Alzheimer disease detection in a new study published in Nature Medicine.

Heart Disease Remains Leading Cause of Death in US: Daily Dose

February 11, 2025

Your daily dose of the clinical news you may have missed.